Today news
The same in other media
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests
Reading now: 670
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.
The companies partnered in February for the development of a vaccine against the novel coronavirus. As part of the collaboration, Applied DNA subsidiary LineaRx agreed to work with Takis Biotech on preclinical development of a linear DNA vaccine based on polymerase chain reaction (PCR).
Applied DNA’s vaccine constructs were produced at scale using plasmid-based vaccine templates. According to Takis Biotech, initial data from animal tests of the vaccine templates showed immunogenicity and a strong antibodies generation across all five vaccine candidates.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|